New drugs trials are being set up to try to halt the development of amyloid plaque accumulations at the earliest stages of Alzheimer’s disease, before significant brain damage occurs. An issue with the trials has been raised by the FDA which says it must know not just that plaque was reduced or eliminated but also […]

Scientists from the University of California-Berkeley have developed a series of tests including PET scans and memory tests which have been significantly more effective in spotting individuals more likely to develop Alzheimer’s Disease. The study, published in the June 30, 2010 issue of Neurology, is important because it is critical to learn who would best […]